Refractory Kawasaki disease - UpToDate
JCI - Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
Molecular and immunological biomarkers to predict IVIg response: Trends in Molecular Medicine
Management of Kawasaki disease | Archives of Disease in Childhood
Frontiers | A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
Clinical Practice Guidelines : Kawasaki disease
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness | PLOS ONE
IJMS | Free Full-Text | Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
IVIG resistance-related cytokines in Kawasaki disease | Download Table
Diagnosis and Management of Kawasaki Disease | AAFP
Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect
Kawasaki Dis Canada su Twitter: "Approximately 10% to 20% of patients with Kawasaki disease develop recrudescent or persistent fever at least 36 hours after the end of their IVIG infusion and are
Frontiers | Kawasaki Disease
Clinical characteristics in Kawasaki disease related to intravenous... | Download Table
Kawasaki disease: an update on diagnosis and treatment. | Semantic Scholar
Kawasaki disease: AHA statement and recommendations
The Role of Neutrophil Activation in the Pathogenesis of Kawasaki Disease | Insight Medical Publishing
Kawasaki Disease: An Update on Diagnosis and Treatment - ScienceDirect
Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin | Semantic Scholar
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health
